
Bahar Alawi Craigo
Examiner (ID: 2811, Phone: (571)270-1326 , Office: P/1673 )
| Most Active Art Unit | 1623 |
| Art Unit(s) | 1759, 1673, 1699, 1623, 4131 |
| Total Applications | 904 |
| Issued Applications | 359 |
| Pending Applications | 130 |
| Abandoned Applications | 452 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17385676
[patent_doc_number] => 20220033528
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-03
[patent_title] => Production of Crystalline Cellulose
[patent_app_type] => utility
[patent_app_number] => 17/450805
[patent_app_country] => US
[patent_app_date] => 2021-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8585
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17450805
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/450805 | Production of Crystalline Cellulose | Oct 12, 2021 | Pending |
Array
(
[id] => 18815983
[patent_doc_number] => 20230390322
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-07
[patent_title] => HIGH CONCENTRATION METHYLCOBALAMIN OR COMBINATION OF METHYL- AND HYDROXY-COBALAMIN FOR THE TREATMENT OF COBALAMIN C DEFICIENCY DISORDERS
[patent_app_type] => utility
[patent_app_number] => 18/032132
[patent_app_country] => US
[patent_app_date] => 2021-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15380
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18032132
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/032132 | HIGH CONCENTRATION METHYLCOBALAMIN OR COMBINATION OF METHYL- AND HYDROXY-COBALAMIN FOR THE TREATMENT OF COBALAMIN C DEFICIENCY DISORDERS | Oct 11, 2021 | Pending |
Array
(
[id] => 17519269
[patent_doc_number] => 20220105117
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-07
[patent_title] => COMPOSITIONS COMPRISING NICOTINAMIDE RIBOSIDE AND A UROLITHIN
[patent_app_type] => utility
[patent_app_number] => 17/497392
[patent_app_country] => US
[patent_app_date] => 2021-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11015
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17497392
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/497392 | Compositions comprising nicotinamide riboside and a urolithin | Oct 7, 2021 | Issued |
Array
(
[id] => 19368312
[patent_doc_number] => 12060382
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-08-13
[patent_title] => Crystalline phases of 5,6-dichloro-2-(isopropylamino)-(1 b-L-ribofuranosyl)-1H-benzimidazole
[patent_app_type] => utility
[patent_app_number] => 17/481980
[patent_app_country] => US
[patent_app_date] => 2021-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 6644
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17481980
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/481980 | Crystalline phases of 5,6-dichloro-2-(isopropylamino)-(1 b-L-ribofuranosyl)-1H-benzimidazole | Sep 21, 2021 | Issued |
Array
(
[id] => 18752404
[patent_doc_number] => 20230355646
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-09
[patent_title] => AUTOPHAGY ACTIVATOR
[patent_app_type] => utility
[patent_app_number] => 18/026057
[patent_app_country] => US
[patent_app_date] => 2021-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16821
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18026057
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/026057 | AUTOPHAGY ACTIVATOR | Sep 16, 2021 | Pending |
Array
(
[id] => 18752404
[patent_doc_number] => 20230355646
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-09
[patent_title] => AUTOPHAGY ACTIVATOR
[patent_app_type] => utility
[patent_app_number] => 18/026057
[patent_app_country] => US
[patent_app_date] => 2021-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16821
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18026057
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/026057 | AUTOPHAGY ACTIVATOR | Sep 16, 2021 | Pending |
Array
(
[id] => 19135582
[patent_doc_number] => 11970512
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-04-30
[patent_title] => Amphotericin B derivatives with improved therapeutic index
[patent_app_type] => utility
[patent_app_number] => 17/464916
[patent_app_country] => US
[patent_app_date] => 2021-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 34
[patent_figures_cnt] => 46
[patent_no_of_words] => 16424
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17464916
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/464916 | Amphotericin B derivatives with improved therapeutic index | Sep 1, 2021 | Issued |
Array
(
[id] => 18709100
[patent_doc_number] => 20230331692
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-19
[patent_title] => TRISULFIDE COMPOUND AND CLATHRATE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/042693
[patent_app_country] => US
[patent_app_date] => 2021-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7449
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18042693
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/042693 | TRISULFIDE COMPOUND AND CLATHRATE THEREOF | Aug 24, 2021 | Pending |
Array
(
[id] => 18709100
[patent_doc_number] => 20230331692
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-19
[patent_title] => TRISULFIDE COMPOUND AND CLATHRATE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/042693
[patent_app_country] => US
[patent_app_date] => 2021-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7449
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18042693
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/042693 | TRISULFIDE COMPOUND AND CLATHRATE THEREOF | Aug 24, 2021 | Pending |
Array
(
[id] => 18709100
[patent_doc_number] => 20230331692
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-19
[patent_title] => TRISULFIDE COMPOUND AND CLATHRATE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/042693
[patent_app_country] => US
[patent_app_date] => 2021-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7449
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18042693
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/042693 | TRISULFIDE COMPOUND AND CLATHRATE THEREOF | Aug 24, 2021 | Pending |
Array
(
[id] => 18628184
[patent_doc_number] => 20230287032
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-14
[patent_title] => SYNTHESIS OF FLUORINATED NUCLEOTIDES
[patent_app_type] => utility
[patent_app_number] => 18/040679
[patent_app_country] => US
[patent_app_date] => 2021-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12540
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18040679
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/040679 | SYNTHESIS OF FLUORINATED NUCLEOTIDES | Aug 10, 2021 | Pending |
Array
(
[id] => 17503429
[patent_doc_number] => 20220096531
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-31
[patent_title] => EYE DROP FORMULATION WITH ENHANCED PROPERTIES BY COMBINING SODIUM HYALURONATE WITH CARBOXYMETHYLCELLULOSE
[patent_app_type] => utility
[patent_app_number] => 17/399504
[patent_app_country] => US
[patent_app_date] => 2021-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6532
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17399504
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/399504 | EYE DROP FORMULATION WITH ENHANCED PROPERTIES BY COMBINING SODIUM HYALURONATE WITH CARBOXYMETHYLCELLULOSE | Aug 10, 2021 | Abandoned |
Array
(
[id] => 17368134
[patent_doc_number] => 20220023186
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-27
[patent_title] => DERMAL FILLER COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 17/396597
[patent_app_country] => US
[patent_app_date] => 2021-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18646
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17396597
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/396597 | DERMAL FILLER COMPOSITIONS | Aug 5, 2021 | Abandoned |
Array
(
[id] => 17226389
[patent_doc_number] => 20210352945
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-18
[patent_title] => OLIGOSACCHARIDE COMPOSITIONS FOR USE IN NUTRITIONAL COMPOSITIONS, AND METHODS OF PRODUCING THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/444063
[patent_app_country] => US
[patent_app_date] => 2021-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 43369
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17444063
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/444063 | OLIGOSACCHARIDE COMPOSITIONS FOR USE IN NUTRITIONAL COMPOSITIONS, AND METHODS OF PRODUCING THEREOF | Jul 29, 2021 | Abandoned |
Array
(
[id] => 17168623
[patent_doc_number] => 20210322293
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-21
[patent_title] => GUAR HYDROXYPROPYLTRIMETHYLAMMONIUM CHLORIDE AND USES THEREOF IN HAIR TREATMENT COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 17/348354
[patent_app_country] => US
[patent_app_date] => 2021-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14325
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17348354
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/348354 | GUAR HYDROXYPROPYLTRIMETHYLAMMONIUM CHLORIDE AND USES THEREOF IN HAIR TREATMENT COMPOSITIONS | Jun 14, 2021 | Pending |
Array
(
[id] => 17503403
[patent_doc_number] => 20220096505
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-31
[patent_title] => PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/346475
[patent_app_country] => US
[patent_app_date] => 2021-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16627
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17346475
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/346475 | PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF | Jun 13, 2021 | Abandoned |
Array
(
[id] => 17368274
[patent_doc_number] => 20220023326
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-27
[patent_title] => ESTERS OF 2-DEOXY-MONOSACCHARIDES WITH ANTI PROLIFERATIVE ACTIVITY
[patent_app_type] => utility
[patent_app_number] => 17/339028
[patent_app_country] => US
[patent_app_date] => 2021-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23526
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17339028
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/339028 | Esters of 2-deoxy-monosaccharides with anti proliferative activity | Jun 3, 2021 | Issued |
Array
(
[id] => 18496113
[patent_doc_number] => 20230218657
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-13
[patent_title] => COMPOSITIONS, THEIR USES IN THERAPY AND METHODS THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/000492
[patent_app_country] => US
[patent_app_date] => 2021-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9036
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18000492
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/000492 | COMPOSITIONS, THEIR USES IN THERAPY AND METHODS THEREOF | Jun 1, 2021 | Pending |
Array
(
[id] => 18510003
[patent_doc_number] => 20230226098
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-20
[patent_title] => ADHESION-PREVENTING AGENT AND METHOD FOR PREVENTING ADHESION USING SAME
[patent_app_type] => utility
[patent_app_number] => 18/007603
[patent_app_country] => US
[patent_app_date] => 2021-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13712
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18007603
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/007603 | ADHESION-PREVENTING AGENT AND METHOD FOR PREVENTING ADHESION USING SAME | May 31, 2021 | Pending |
Array
(
[id] => 18510003
[patent_doc_number] => 20230226098
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-20
[patent_title] => ADHESION-PREVENTING AGENT AND METHOD FOR PREVENTING ADHESION USING SAME
[patent_app_type] => utility
[patent_app_number] => 18/007603
[patent_app_country] => US
[patent_app_date] => 2021-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13712
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18007603
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/007603 | ADHESION-PREVENTING AGENT AND METHOD FOR PREVENTING ADHESION USING SAME | May 31, 2021 | Pending |